Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Human Dopamine Receptor D1 ELISA Kit (AC3654)
Cat.#: ASET-2243
Specifications
Description Human Dopamine Receptor D1 ELISA Kit allows for the in vitro quantitative determination of human Dopamine Receptor D1 concentrations in serum, plasma, tissue homogenates, and other biological fluids. The kit employs the sandwich enzyme immunoassay technique. Size 96T Sample Type Serum, plasma, tissue homogenates, and other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 0.188 ng/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 0.313-20 ng/mL Assay Time 4h 30m Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-2385 Human ECE2 ELISA Kit (AC3796) Quantitative inquiry ASET-1407 Human BMAL1 ELISA Kit (AC2818) Quantitative inquiry ASET-1383 Human EPHA10 ELISA Kit (AC2794) Quantitative inquiry ASET-1239 Mouse AGRP ELISA Kit (AC2650) Quantitative inquiry ASET-2165 Human PZP ELISA Kit (AC3576) Quantitative inquiry ASET-2039 Human Gemin 2 ELISA Kit (AC3450) Quantitative inquiry ASET-2377 Human SRD5A1 ELISA Kit (AC3788) Quantitative inquiry ASET-2524 Rat VEGFB ELISA Kit (AC3935) Quantitative inquiry ASET-2052 Mouse OPA1 ELISA Kit (AC3463) Quantitative inquiry ASET-1538 Rat FOXO1A ELISA Kit (AC2949) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket